Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbas F, Scardino PT (1997) The natural history of clinical prostate carcinoma. Cancer 80:827–833
Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. J Am Med Assoc 280:975–980
Amols HI, Zaider M, Hayes MK, Schiff PB (1997) Physician/ patient-driven risk assignment in radiation oncology: Reality or fancy? Int J Radiat Oncol Biol Phys 38:455–461
Brahme A (2001) Individualizing cancer treatment: biological optimization models in treatment planning and delivery. Int J Radiat Oncol Biol Phys 49:327–337
Brahme A, Nilsson J, Belkic D (2001) Biologically optimized radiation therapy. Acta Oncol 40:725–734
Chambers L (1995) Practical handbook of genetic algorithms. CRC Press, Boca Raton, Florida
Chodak GW (1998) Comparing treatments for localized prostate cancer-persisting uncertainty. J Am Med Assoc 280:1008–1010
Cohen GN, Amols HI, Zelefsky MJ, Zaider M (2002) The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitioners. Int J Radiat Oncol Biol Phys 53:504–511
Critz FA, Williams WH, Levinson AK, Benton JB, Holladay CT, Schnell FJ (2000) Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. J Urol 164:738–741
D’souza WD, Thames HD, Kuban DA (2004) Dose-volume conundrum for response of prostate cancer to brachytherapy: summary of dosimetric measures and their relationship to tumor control probability. Int J Radiat Oncol Biol Phys 58:1540–1548
Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679–694
Gallagher RJ, Lee EK (1997) Mixed integer programming optimization models for brachytherapy treatment planning. Proc MIA Annual Fall Symposium, pp 278–282
Grefenstette JJ, American Association for Artificial Intelligence, Bolt BaNi, Naval Research Laboratory (U.S.) (1987) Genetic algorithms and their applications. Proc Second International Conference on Genetic Algorithms, 28–31 July 1987, Massachusetts Institute of Technology, Cambridge, Massachusetts. Erlbaum, Hillsdale, New Jersey
Haworth A, Ebert M, Waterhouse D, Joseph D, Duchesne G (2004a) Assessment of I-125 prostate implants by tumor bioeffect. Int J Radiat Oncol Biol Phys 59:1405–1413
Haworth A, Ebert M, Waterhouse D, Joseph D, Duchesne G (2004b) Prostate implant evaluation using tumour control probability: the effect of input parameters. Phys Med Biol 49:3649–3664
Jani AB, Hellman S (2003) Early prostate cancer: clinical decision-making. Lancet 361:1045–1053
King CR, DiPetrillo TA, Wazer DE (2000) Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models. Int J Radiat Oncol Biol Phys 46:165–172
Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P (1995) Ctrate as an in-vivo marker to discriminate prostate-cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45:459–466
Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.1 cm3) spatial resolution. Radiology 198:795–805
Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H (2000a) The prostate: MR imaging and spectroscopy-present and future. Radiol Clin North Am 38:115
Kurhanewicz J, Vigneron DB, Nelson SJ (2000b) Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2:166–189
Lee EK, Zaider M (2001) On the determination of an effective planning volume for permanent prostate implants. Int J Radiat Oncol Biol Phys 49:1197–1206
Lee EK, Gallagher RJ, Silvern D, Wuu CS, Zaider M (1999) Treatment planning for brachytherapy: an integer programming model, two computational approaches and experiments with permanent prostate implant planning. Phys Med Biol 44:145–165
Lee SP, Leu MY, Smathers JB, McBride WH, Parker RG, Withers HR (1995) Biologically effective dose distribution based on the linear-quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys 33:375–389
MacKay RI, Hendry JH, Moore CJ, Williams PC, Read G (1997) Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol 70:517–526
Man KF, Tang KS, Kwong S (1999) Genetic algorithms concepts and designs. Springer, Berlin Heidelberg, New York
McGregor M, Hanley JA, Boivin JF, Mclean RG (1998) Screening for prostate cancer: estimating the magnitude of overdetection. Can Med Assoc J 159:1368–1372
Mizowaki T, Cohen G, Fung AYC, Zaider M (2002) Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 54:1558–1564
Nag S, Shasha D, Janjan N, Petersen I, Zaider M (2001) The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys 49:1033–1043
Peschel RE, Colberg JW (2003) Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 4:233–241
Pouliot J, Tremblay D, Roy J, Filice S (1996) Optimization of permanent I-125 prostate implants using fast simulated annealing. Int J Radiat Oncol Biol Phys 36:711–720
Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA (2000) Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 48:643–647
Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213:473–480
Silvern DA (1998) Automated OR prostate brachytherapy treatment planning using genetic optimization. Thesis, Columbia University, New York
Sloboda RS (1992) Optimization of brachytherapy dose distribution by simulated annealing. Med Phys 19:964
Todor DA, Cohen GN, Amols HI, Zaider M (2002a) Operator-free, film-based 3D seed reconstruction in brachytherapy. Phys Med Biol 47:2031–2048
Todor DA, Cohen GN, Amols HI, Zaider M (2002b) Operator-free, film-based 3D seed reconstruction in brachytherapy. Phys Med Biol 47:2031–2048
Todor DA, Zaider M, Cohen GN, Worman MF, Zelefsky MJ (2003) Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol 48:1153–1171
Tubic D, Zaccarin A, Pouliot J, Beaulieu L (2001) Automated seed detection and three-dimensional reconstruction. I. Seed localization from fluoroscopic images or radiographs. Med Phys 28:2265–2271
Wang JZ, Li XA (2003) Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys 30:34–40
Waterman FM, Yue N, Corn BW, Dicker AP (1997) Edema associated with I-125 or Pd-103 prostate brachytherapy and its effect on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 39:220
Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404
Zaider M, Minerbo GN (2000) Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol 45:279–293
Zaider M, Zelefsky MJ, Lee EK, Zakian KL, Amols HI, Dyke J, Cohen G, Hu Y, Endi AK, Chui C, Koutcher JA (2000) Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 47:1085–1096
Zaider M, Zelefsky M, Cohen AM, Chui C, Yorke ED, Ben-Porat L, Happersett MA (2005) Methodology for biologically based treatment planning for combined low dose-rate (permanent implant) and high dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys 61:702–713
Zalzala AMS, Fleming PJ (1997) Genetic algorithms in engineering systems. Institution of Electrical Engineers, London
Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE (2000a) Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47:1261–1266
Zelefsky MJ, Cohen G, Zakian KL, Dyke J, Koutcher JA, Hricak H, Schwartz L, Zaider M (2000b) Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J 6:249–255
Zhang M, Zaider M, Worman M, Cohen G (2004) On the question of 3D seed reconstruction in prostate brachytherapy: the determination of X-ray source and film locations. Phys Med Biol 49:N335–N345
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zaider, M. (2006). Permanent-Implant Brachytherapy in Prostate Cancer. In: Schlegel, W., Bortfeld, T., Grosu, AL. (eds) New Technologies in Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29999-8_29
Download citation
DOI: https://doi.org/10.1007/3-540-29999-8_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00321-2
Online ISBN: 978-3-540-29999-8
eBook Packages: MedicineMedicine (R0)